NASDAQ:IMCR
Immunocore Holdings plc Stock News
$53.29
-0.96 (-1.77%)
At Close: May 17, 2024
Best Momentum Stocks to Buy for January 10th
11:19am, Wednesday, 10'th Jan 2024
IMCR, CPRX and AMPX made it to the Zacks Rank #1 (Strong Buy) momentum stocks list on January 10, 2024.
New Strong Buy Stocks for January 10th
07:31am, Wednesday, 10'th Jan 2024
PCRFY, IMCR, CPRX, AMPX and ENS have been added to the Zacks Rank #1 (Strong Buy) List on January 10, 2024.
Immunocore announces strategic priorities and pipeline expansion ahead of 42 nd Annual J.P. Morgan Healthcare Conference presentation
Immunocore to present at the 42nd Annual J.P. Morgan Healthcare Conference
07:00am, Wednesday, 03'rd Jan 2024
Immunocore to present at the 42 nd Annual J.P. Morgan Healthcare Conference
Immunocore Holdings PLC Sponsored ADR (IMCR) Upgraded to Buy: Here's What You Should Know
01:32pm, Monday, 18'th Dec 2023
Immunocore Holdings PLC Sponsored ADR (IMCR) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the ne
Can Immunocore Holdings PLC Sponsored ADR (IMCR) Climb 75.55% to Reach the Level Wall Street Analysts Expect?
11:17am, Monday, 27'th Nov 2023
The consensus price target hints at a 75.6% upside potential for Immunocore Holdings PLC Sponsored ADR (IMCR). While empirical research shows that this sought-after metric is hardly effective, an upwa
Wall Street Analysts See a 66.42% Upside in Immunocore Holdings PLC Sponsored ADR (IMCR): Can the Stock Really Move This High?
11:16am, Friday, 10'th Nov 2023
The mean of analysts' price targets for Immunocore Holdings PLC Sponsored ADR (IMCR) points to a 66.4% upside in the stock. While this highly sought-after metric has not proven reasonably effective, s
Immunocore to present at upcoming investor conferences
04:30pm, Monday, 30'th Oct 2023
Immunocore to present at upcoming investor conferences (OXFORDSHIRE, England & CONSHOHOCKEN, Penn. & ROCKVILLE, Md.
Immunocore to present at upcoming investor conferences
05:00pm, Monday, 11'th Sep 2023
Immunocore to present at upcoming investor conferences (OXFORDSHIRE, England & CONSHOHOCKEN, Penn. & ROCKVILLE, Md.
Institutions are Buying These 3 Stocks and Analysts Agree
10:05am, Thursday, 07'th Sep 2023
A significant but less-spoken or popular metric that investors should keep a watchful eye on is the institutional flow of capital into individual stocks. Institutional buying, often called "smart mone
Immunocore to present at upcoming investor conferences
04:00pm, Friday, 01'st Sep 2023
Immunocore to present at upcoming investor conferences (OXFORDSHIRE, England & CONSHOHOCKEN, Penn. & ROCKVILLE, Md.
Immunocore: KIMMTRAK Adoption Continues At Rapid Pace, Expanding To New Markets, Reiterate Buy
12:28pm, Sunday, 27'th Aug 2023
Immunocore's KIMMTRAK segment continues to see rapid adoption, expanding into additional European markets and Israel. The launch curve of KIMMTRAK has been impressive, with TTM revenues up 494% from Q
Immunocore to report second quarter 2023 financial results and host call on August 10, 2023
08:00am, Thursday, 03'rd Aug 2023
Immunocore to report second quarter 2023 financial results and host call on August 10, 2023
August MDA Breakout Stocks Week 31 - 2023: High-Frequency Gainers To Give You An Edge
02:43pm, Monday, 31'st Jul 2023
Two new Breakout Stocks for Week 31 curated by the MDA model for 10% short-term upside and additional model selections. This week two of four picks gained over 10% in less than a week with peak gains
Immunocore Holdings: Unlocking The Immune System's Hidden Potential
03:49am, Sunday, 11'th Jun 2023
Immunocore Holdings is a leading biotech firm with a promising pipeline of T cell receptor-based bispecific immunotherapies for cancer, autoimmune diseases, and infectious illnesses. Immunocore's fina
